Amresh Kumar
CIK: 0001978220
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GRCE
Grace Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Kumar Amresh
Kumar Amresh (SEC CIK 0001978220) files insider reports with the SEC as VP Program Management of Grace Therapeutics, Inc. (GRCE).
Signal8 holds 2 ownership filings by Kumar Amresh, all Form 4s, filed between Apr 16, 2025 and Sep 1, 2026. Those filings report 2 transactions, from Apr 14, 2025 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kumar Amresh's filings is in PRINCETON, NJ.
Recent filings by Kumar Amresh
Other insiders filing for Grace Therapeutics, Inc. (GRCE)
- Opaleye Management Inc., 10% Owner
- NEUGEBOREN EDWARD, Director
- DAVIS A BRIAN, Director
- Kavuru Vimal, Director
- Kottayil George, Director
- Kohli Prashant, Chief Executive Officer